FINEOS (ASX:FCL) share price under spotlight with HY21 repor

FINEOS (ASX:FCL) share price under spotlight with HY21 report, new contract win


The
FINEOS Corporation Holdings PLC(ASX: FCL) share price will be on watch tomorrow after the insurance software business released its FY21 half-year result. It also announced a new contract.
Why the FINEOS share price will be on the radar
The FINEOS share price will be in focus tomorrow after the company told investors its half-year revenue increased by 30.1% to €52.6 million. This was made up of 20.1% organic growth and 10% growth from acquisition.
Software revenue was €19.1 million. There was organic subscription recurring revenue growth of 35.1% year on year, or 51.5% growth including the contribution from a US acquisition called Limelight Health (LLH) which was acquired in August 2020. Initial license fee (ILF) revenue was down 16.8% to €1.5 million, reflecting a run off of the old pricing model revenue.

Related Keywords

Australia , New Zealand , Australian , Tracey Lonergan , Scott Phillips , Limelight Health , Corporation Holdings , Partners Life , Motley Fool Share Advisor , ஆஸ்திரேலியா , புதியது ஜீலாந்து , ஆஸ்திரேலிய , ட்ரேசி லொனேர்காண் , ஸ்காட் பிலிப்ஸ் , வெளிச்சம் ஆரோக்கியம் , நிறுவனம் ஹோல்டிங்ஸ் , கூட்டாளர்கள் வாழ்க்கை ,

© 2025 Vimarsana